Zheng Quan Shi Bao Wang·2025-08-01 09:40Group 1 - The animal vaccine sector experienced a rise of 2.22%, leading the concept sectors in terms of growth, with 13 stocks increasing in value, including Shenyuan Biological which hit the daily limit, and Yongshun Biological, Kexing Pharmaceutical, and Jinhai Biological showing notable gains of 6.32%, 4.08%, and 3.32% respectively [1][2] - The main inflow of funds into the animal vaccine sector amounted to a net inflow of 51 million yuan, with Kexing Pharmaceutical receiving the highest net inflow of 72.79 million yuan, followed by Shenyuan Biological, Kanghua Biological, and Xianfeng Holdings with net inflows of 57.81 million yuan, 46.82 million yuan, and 7.03 million yuan respectively [2][3] - The net inflow ratios for Shenyuan Biological, Xianfeng Holdings, and Kexing Pharmaceutical were 23.96%, 11.45%, and 9.02% respectively, indicating strong investor interest in these stocks [3] Group 2 - The animal vaccine sector's performance was contrasted by declines in other sectors, such as the China Shipbuilding System which fell by 2.54%, and the military equipment restructuring concept which decreased by 1.90% [2] - The trading volume and turnover rates for leading stocks in the animal vaccine sector were significant, with Shenyuan Biological showing a turnover rate of 7.26% and Kexing Pharmaceutical at 7.15% [3][4] - Several stocks within the animal vaccine sector experienced negative net inflows, including Guoyao Modern, Biological Shares, and Zhongmu Shares, which saw declines of 0.70%, 0.58%, and 0.52% respectively [1][4]